slides · global inventory
Disclaimer
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 41,127
Current window 28,201-28,230
Pages 1,371
Rows per page 30
Component
28,201-28,230 of 41,127
10
The slide uses CER (Constant Exchange Rate) for growth comparisons.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
17
Includes a line chart showing market share trends for Calquence vs competitors in the BTKi class.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
The slide uses a comparison structure to highlight two distinct drug candidates.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Aha Moment1 hit
23
The slide uses a split-screen comparison of two distinct clinical trial datasets.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
24
Includes footnotes defining abbreviations and trial details.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
Includes a detailed legend of medical abbreviations at the bottom.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
31
Includes specific Scope 1, 2, and 3 emission reduction targets and a carbon negative goal.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
34
The slide uses a custom matrix layout to show drug positioning across patient segments (HER2-high, HR+, HER2-low, etc.) and treatment lines (Early to 3rd-line+).AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
35
Includes detailed footnotes regarding pro-forma growth calculations and definitions of EM, CVRM, R&I, and V&I.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
43
Data reflects revenue post-acquisition of Alexion on 21 July 2021.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
44
AstraZeneca | Results Presentation Deck | 44 slidesAstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations 1 hit
02
Includes a specific date reference in the footer: October 31st, 2022.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
15
Includes chemical structure diagrams and multiple bar charts showing dose-response relationships.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
32
Includes a summary table on the left and clinical trial data/roadmap on the right.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
02
Auto Trader Group | Results Presentation Deck | 34 slidesAuto Trader Group | Results Presentation Deck | 34 slides · Auto Trader
Conference presentation Investor relations 1 hit
19
Includes detailed footnotes explaining adjustments for stock-based compensation, acquisition costs, inventory, and tax impacts.Azek | Results Presentation Deck | 20 slides · The AZEK Company
Conference presentation Investor relations 1 hit
10
The slide uses a combination of a bar chart for historical performance and a list of strategic initiatives.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
The slide uses a hub-and-spoke style layout to show how these five pillars integrate into the Azerion platform.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
30
Includes a central donut chart for gender split and unique monthly plays, flanked by two bar charts for age and geography.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations 1 hit
32
The slide uses a timeline structure to demonstrate M&A momentum. It includes flags to indicate the geographic origin of acquired companies.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations 1 hit
33
The slide uses a comparison table to highlight the strategic rationale behind specific M&A activities.Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations 1 hit
36
Includes a disclaimer about accounting standards (Dutch GAAP vs IFRS).Azerion | Investor Presentation Deck | 45 slides · Azerion
Pitch deck Investor relations Beat · Financials1 hit
02
Bausch Health Companies | Results Presentation Deck | 48 slidesBausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
10
Includes non-GAAP measures and specific segment performance drivers.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The slide uses a combination of bar charts and donut charts to visualize revenue performance and segment composition.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
Includes constant currency adjustments and detailed footnotes regarding non-GAAP measures.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The table uses a waterfall-style bridge logic to show the impact of Bausch + Lomb on the consolidated guidance.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
21
The slide highlights a change in the Adjusted Tax Rate from ~15% to ~17%.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
30
Includes footnotes regarding non-GAAP measures, share counts, and exclusions for cash flow.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit
37
The slide presents two identical table structures for two different time periods.Bausch Health Companies | Results Presentation Deck | 48 slides · Bausch Health
Conference presentation Investor relations 1 hit